PIERS and BIS, sFIT:PIGF, Adrenomedullin

ConditionEclampsia

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexFemale

Age18-50

SponsorSuez Canal University

About this trial

Pre-eclampsia, more than being proteinuric gestational hypertension alone, is a state of exaggerated systemic inflammation and remains a leading direct cause of maternal morbidity and mortality worldwide.1 Standardization of antenatal and postnatal assessment and surveillance of pre-eclampsia with protocols that recognize the systemic inflammatory model of preeclampsia have been associated with reduced maternal morbidity.

Eligibility criteria

Qualifiers

Pregnancy at any stage (3 trimesters)

Eclampsia (Frank eclampsia) will be the crux of the study

Pre-eclampsia that is suspected will end up with Frank Eclampsia

Disqualifiers

Any neurological conditions that can alter the electroencephalography like epilepsy

Any medical conditions that can alter the electroencephalography like hypoglycemia

Trial design

Treatments tested in this trial

Not listed

Trial groups

48 Participants

are grouped into 2 trial groups

Sponsors and collaborators

Suez Canal University

Lead sponsor

University of Malaya

Collaborator

Source ClinicalTrials.gov